Clinical Trial Update: The Study to Reevaluate the Safety and Efficacy of Human Urinary Kallikrein [Phase 4]

View source ↗

Summary

A Phase 4 trial update studying human urinary kallikrein for safety and efficacy in cerebral infarction; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Infarction

Drugs mentioned

• Human Urinary Kallikrein

Snippet

Sponsor: Techpool Bio-Pharma Co., Ltd. | Conditions: Cerebral Infarction | Phase 4 | Status: UNKNOWN